• Most Popular
  • Most Shared

Mylan wins U.S. approval for Zoloft generic

NEW YORK
Tue Feb 6, 2007 2:50pm EST

Stocks

   

NEW YORK (Reuters) - Mylan Laboratories Inc. MYL.N said on Tuesday it won U.S. approval for its generic versions of Pfizer Inc.'s (PFE.N) blockbuster anti-depressant Zoloft.

Mylan said it would ship its product immediately. Zoloft's generic name is sertraline hydrochloride.



More from Reuters

Photo

Sturdy U.S. home sales bolster economic growth prospects

WASHINGTON (Reuters) - Sales of previously owned U.S. homes jumped last month to their highest level in nearly three years, the latest sign that the economic recovery was gaining steam, after growing below expectations in the third quarter.

Guadalupe Hernandez receives an ultrasound by nurse practitioner Gail Brown during a prenatal exam at the Maternity Outreach Mobile in Phoenix, Arizona October 8, 2009. Credit: REUTERS/Joshua Lott

Health reform inches closer

Democrats are on the verge of passing landmark legislation by Christmas, with only one more hurdle remaining.  Full Article | Video 

Photo

The end of the carry trade?

Borrowing the dollar cheaply to fund purchases of higher-yielding assets was a no-brainer in 2009, but will it be a safe bet in 2010?  Full Article